Welcome to the Ferring COVID-19 Investigational Grants.
Thank you for participating in the Ferring COVID-19 Investigational Grants program. The portal is now closed. Submitted applications will receive an email on the status of their application by July 31st.
Ferring COVID-19 Investigational Grants in Reproductive Medicine and Maternal Health Overview:
What is of Interest to Ferring
Ferring is interested in funding exploratory, basic, and clinical research grants to collect data and expand knowledge about the effects of SARS-CoV-2 on reproduction, pregnancy, and foetal/neonatal health.
The Ferring COVID-19 Investigational Grants in Reproductive Medicine and Maternal Health (RMMH) are designed to provide funding to gather data related to IVF programmes during the COVID-19 pandemic including but not limited to:
- Follow-up data on infected pregnant patients at different gestational stages, including spontaneous pregnancies.
- Data on the outcome of ongoing fertility care.
- Data on gametes/embryos, fresh or frozen, from patients exposed to SARS-CoV-2.
- Other information related to fertility outcomes.
The Ferring COVID-19 Investigational Grants are awarded a single time and are not renewable.
The programme will provide a limited number of research grants up to EUR 25,000 for each application.
Intellectual Property and License to Data and Results
Ferring does not intend to claim ownership to data or intellectual property generated from these grants. Ownership is assumed by the grant applicant and may be subject to the policies of the grant recipient’s institution. Ferring will be and is hereby granted a worldwide, non-exclusive, royalty-free, right and license (with the right to sublicense) to access, refer to, and otherwise use the anonymized research data, information, and other results, including intellectual property generated as part of the research project for any purposes.